Jim-Min Fang

This inventor holds 30 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Academia Sinica, National Taiwan University, Tripod Nano Technology Corporation. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jim-Min Fang. Retrieved from https://idiyas.com/inventor/jim-min-fang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 5)

% Patents Active = 86.7

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 18)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 176(Granted Patents)

Location History:

Taoyuan, TW (2018)
Taipei, TW (2001 - 2023)

Company Filing History:

National Taiwan University

patents

3 out of 3

Tripod Nano Technology Corporation

patents

4. 2 out of 9

Tripod Technology Corporation

patents

5. 1 out of 3

Allied Industrial Corp., Ltd.

patents

6. 1 out of 12

Council of Agriculture, Executive Yuan

patents

7. 1 out of 544

National Science Council

patents

8. 1 out of 1,247

National Yang Ming Chiao Tung University

patents

9. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Analgesic Compounds

Colloidal Nanoparticles

Anticancer Activity

Neurodegenerative Diseases

Anti-Influenza Agents

Sialidase Probes

Reactive Labelling

DNA Repair Toxicity

Histone Deacetylase Inhibitors

Adenosine Analogue

Optical Sensors

Ferrocenyl Compounds

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129273 - Compound with analgesic effect for use in prevention and treatment of pain (2024-10-29),

2. 11753432 - Compound with analgesic effect for use in prevention and treatment of pain (2023-09-12),

3. 11439979 - Method of making colloidal selenium nanoparticles (2022-09-13),

4. 11179781 - Method of making colloidal platinum nanoparticles (2021-11-23),

5. 10865121 - Method of making an inorganic platinum compound (2020-12-15),

6. 10765681 - Purine compounds possessing anticancer activity (2020-09-08),

7. 10342818 - [object Object] (2019-07-09),

8. 10301348 - Compounds for use in prevention and treatment of neurodegenerative diseases and pain (2019-05-28),

9. 10214765 - Cell-permeable probes for identification and imaging of sialidases (2019-02-26),

10. 10130714 - Enhanced anti-influenza agents conjugated with anti-inflammatory activity (2018-11-20),

11. 10119972 - Reactive labelling compounds and uses thereof (2018-11-06),

12. 10117890 - Methods and compositions for treating pain (2018-11-06),

13. 10099191 - Method of making colloidal metal nanoparticles (2018-10-16),

14. 10046976 - Method of making inorganic gold compound (2018-08-14),

15. 9914956 - Cell-permeable probes for identification and imaging of sialidases (2018-03-13),

Title: Innovations in Pain Management: The Contributions of Jim-Min Fang

Introduction

Jim-Min Fang is a prominent inventor based in Taipei, Taiwan, recognized for his significant contributions to the field of pain management through innovative compounds. With a total of 30 patents to his name, Fang has been at the forefront of developing solutions aimed at alleviating pain and improving the quality of life for many.

Latest Patents

Among Fang's latest inventions are several notable patents focused on compounds with analgesic effects for both the prevention and treatment of pain. One such compound is identified as 5'-glycylcarbonyl-N-(4-hydroxybenzyl)adenosine (I-a1), derived from the conjugation of N-(4-hydroxybenzyl)adenosine with amino acids or peptides. Another innovative compound is 5′-deoxy-5′-(N′-glycylureido)-N-(4-hydroxybenzyl)adenosine (I-d1). Additionally, he has developed methods for the creation and application of these compounds, aiming to enhance their effectiveness in pain management.

Career Highlights

Jim-Min Fang has held key positions at prestigious institutions including Academia Sinica and National Taiwan University, where he has contributed to significant research and development efforts. His work has not only advanced the scientific community’s understanding of pain management but has also paved the way for new therapeutic alternatives.

Collaborations

Throughout his career, Fang has collaborated with esteemed colleagues such as Chi-Huey Wong and Jiun-Jie Shie. These partnerships have led to fruitful exchanges of ideas and have further propelled advancements in the field of pharmacological research.

Conclusion

In summary, Jim-Min Fang stands out as a significant figure in the realm of innovations for pain management. His 30 patents, particularly those concerning novel analgesic compounds, reflect his dedication to improving healthcare solutions. As he continues to collaborate and innovate, Fang’s impact on the field will likely resonate for years to come.

Profile summary based on public USPTO records.